2-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Gastroenterology...
Stomach & Duodenum
Browse
ALL OF MEDICINE
Gastroenterology & Hepatology
Biliary Tract
Clinical Nutrition
Colon & Rectum
Disorders of Neurogastroenterology & Motility
Endoscopy
Esophagus
Gastrointestinal Cancers
Gastrointestinal Infections
Inflammatory Bowel Disease
Liver Biology & Pathobiology
Liver Failure & Liver Disease
Pancreas
Small Intestine
Stomach & Duodenum
Related Sections
Diabetes & Obesity
Renal & Gastrointestinal Problems in Critical Care
selected for
My F1000 Medicine
Browse > Gastroenterology & Hepatology > Stomach & Duodenum
Current Top 10 by F1000 Factor
/
All Time Top 10 by F1000 Factor
/
Most viewed
(from all journals)
/
Most viewed
(from specialty journals)
/
Hidden jewels
Page 1 of 6. Select Page:
1
2
3
4
5
6
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
hypotheses
new findings
confirmations
tech advances
controversial
refutation
dissenting
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
Hypothesis
New Finding
Association of Amino Acid Substitutions in the i-Region of the vacA Gene of Helicobacter pylori with Gastric Diseases in Taiwan.
Sheu SM, Hung KH, …, Yang HB, Wu JJ
J Clin Microbiol
2008 Nov 19 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Yoshio Yamaoka
Evaluated 2 Dec 2008
Recommended
F1000 Factor
3.0
Hypothesis
New Finding
Controversial
Esomeprazole induces upper gastrointestinal tract transmucosal permeability (R2).
Mullin JM, Valenzano MC, …, Mercogliano G, Thornton AJ
Aliment Pharmacol Ther
2008 Aug 4
28
[
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Ingvar Bjarnason
Evaluated 27 Nov 2008
Recommended
F1000 Factor
3.0
Confirmation
Tech Advance
Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation.
Wells CD, Harrison ME, …, Depetris G, Sharma VK
Gastrointest Endosc
2008 Aug
68
(2):231-6 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Andrew Dupont with Advitya Malhotra
Evaluated 26 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
Evaluation of the Clinical Significance of homB, a Novel Candidate Marker of Helicobacter pylori Strains Associated with Peptic Ulcer Disease.
Oleastro M, Cordeiro R, …, Mégraud F, Ménard A
J Infect Dis
2008 Nov 1
198
(9):1379-87 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Jay Solnick
Evaluated 5 Nov 2008
Recommended
F1000 Factor
3.0
Confirmation
Hypothesis
A multicenter randomized comparison of the Endocapsule and the Pillcam SB.
Cave DR, Fleischer DE, …, Lee M, Bhattacharya K
Gastrointest Endosc
2008 Sep
68
(3):487-94 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Nigel Umar Beejay
Evaluated 28 Oct 2008
Recommended
F1000 Factor
3.0
New Finding
Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: A population-based study.
Dong CX, Deng DJ, …, Zhou J, You WC
Int J Cancer
2008 Sep 26 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Pelayo Correa
Evaluated 27 Oct 2008
Must Read
F1000 Factor
6.0
New Finding
Reprimo as a potential biomarker for early detection in gastric cancer.
Bernal C, Aguayo F, …, Barrientos C, Corvalan AH
Clin Cancer Res
2008 Oct 1
14
(19):6264-9 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Pelayo Correa
Evaluated 17 Oct 2008
Recommended
F1000 Factor
3.0
Confirmation
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
Gilard M, Arnaud B, …, Abgrall JF, Boschat J
J Am Coll Cardiol
2008 Jan 22
51
(3):256-60 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| John Augoustides
Evaluated 16 Oct 2008
Must Read
F1000 Factor
6.4
Hypothesis
New Finding
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.
Kaser A, Lee AH, …, Glimcher LH, Blumberg RS
Cell
2008 Sep 5
134
(5):743-56 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Tor Savidge / Eduard Stange
First evaluation 7 Oct 2008 | Latest evaluation 12 Oct 2008
Recommended
F1000 Factor
3.0
Confirmation
Hypothesis
Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
de Abajo FJ, García-Rodríguez LA
Arch Gen Psychiatry
2008 Jul
65
(7):795-803 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Ian Beales
Evaluated 7 Oct 2008
top of page
Page 1 of 6. Select Page:
1
2
3
4
5
6
>>
Display
10
/
20
/
50
papers per page
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info